{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:01:31Z","timestamp":1794434491644,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0532800"],"award-info":[{"award-number":["2024ZD0532800"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019FY101200"],"award-info":[{"award-number":["2019FY101200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","award":["I-24PJ0216"],"award-info":[{"award-number":["I-24PJ0216"]}],"id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijantimicag.2026.107774","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:07:56Z","timestamp":1773680876000},"page":"107774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ceftazidime\/avibactam-resistant carbapenem-resistant Klebsiella pneumoniae in China: A nationwide multicenter study"],"prefix":"10.1016","volume":"67","author":[{"given":"Rongqi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binrong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107774_bib0001","series-title":"Global action plan on antimicrobial resistance","year":"2015"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0002","series-title":"Antibiotic resistance threats in the United States, 2019","year":"2019"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0003","series-title":"Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","year":"2024"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107341","article-title":"In-vitro activities of essential antimicrobial agents including aztreonam\/avibactam, eravacycline, colistin and other comparators against carbapenem-resistant bacteria with different carbapenemase genes: a multi-centre study in China, 2021","volume":"64","author":"Wu","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jac\/dkae450","volume":"80","author":"Bianco","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0006","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12866-021-02293-0","article-title":"Increased gene expression and copy number of mutated blaKPC lead to high-level ceftazidime\/avibactam resistance in Klebsiella pneumoniae","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106090","article-title":"Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis","volume":"179","author":"Karampatakis","year":"2023","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13613-023-01153-6","article-title":"Rationale and evidence for the use of new beta-lactam\/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients","volume":"13","author":"Barbier","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"2","key":"10.1016\/j.ijantimicag.2026.107774_bib0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0010","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1128\/CMR.00115-20","article-title":"New \u03b2-lactam-\u03b2-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0011","series-title":"Ceftazidime-avibactam. Center for Drug Evaluation and Research. Approval package for application number 206494Orig1s000. AVYCAZ injection","year":"2015"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0012","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01854-22","article-title":"In vitro activity of new \u03b2-lactam-\u03b2-lactamase inhibitor combinations and comparators against clinical isolates of gram-negative bacilli: results from the China Antimicrobial Surveillance Network (CHINET) in 2019","volume":"10","author":"Guo","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0013","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2361007","article-title":"Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent Klebsiella pneumoniae","volume":"13","author":"Shi","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0014","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02431-18","article-title":"Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the in vitro activities of ceftazidime-avibactam and ceftolozane-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa","volume":"63","author":"Yin","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0015","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","year":"2018"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0016","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2025"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0017","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0018","article-title":"Increased expression and amplification of blaKPC-2 contributes to resistance to ceftazidime\/avibactam in a sequence type 11 carbapenem-resistant Klebsiella pneumoniae strain","volume":"10","author":"Li","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0019","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2014.10.006","article-title":"Emergence of blaKPC carbapenemase genes in Australia","volume":"45","author":"Partridge","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jgar.2021.02.020","article-title":"A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae","volume":"25","author":"Lan","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127839","article-title":"Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: a global public health threat","volume":"288","author":"Lei","year":"2024","journal-title":"Microbiol Res"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0022","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1124\/pharmrev.120.000020","article-title":"Rescuing the last-line polymyxins: achievements and challenges","volume":"73","author":"Nang","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13756-023-01331-y","article-title":"Infection with carbapenem-resistant hypervirulent Klebsiella pneumoniae: clinical, virulence and molecular epidemiological characteristics","volume":"12","author":"Li","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12941-025-00827-2","article-title":"Resistance profile and influence factors of carbapenem-resistant Klebsiella pneumoniae (CRKP) causing infections in China: a systematic review and meta-analysis","volume":"24","author":"Yang","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102599","article-title":"The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings","volume":"51","author":"Gao","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0026","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1038\/s41467-021-25120-6","article-title":"Etiological and epidemiological features of acute respiratory infections in China","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0027","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13052-017-0398-0","article-title":"A comparison of blood stream infections with extended spectrum beta-lactamase-producing and non-producing Klebsiella pneumoniae in pediatric patients","volume":"43","author":"Tan\u0131r Basaranoglu","year":"2017","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00776-18","article-title":"Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae","volume":"56","author":"Russo","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101083","article-title":"Expansion and transmission dynamics of high risk carbapenem-resistant Klebsiella pneumoniae subclones in China: An epidemiological, spatial, genomic analysis","volume":"74","author":"Wang","year":"2024","journal-title":"Drug Resist Updat"},{"issue":"21","key":"10.1016\/j.ijantimicag.2026.107774_bib0030","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.scib.2023.09.040","article-title":"\u201cSuperbugs\u201d with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China","volume":"68","author":"Pu","year":"2023","journal-title":"Sci Bull (Beijing)"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100918","article-title":"Characterization difference of typical KL1, KL2 and ST11-KL64 hypervirulent and carbapenem-resistant Klebsiella pneumoniae","volume":"67","author":"Zhou","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0032","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1038\/s41467-024-49349-z","article-title":"International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe","volume":"15","author":"Budia-Silva","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2022.106679","volume":"60","author":"Lee","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0031","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/22221751.2022.2049458","article-title":"Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China","volume":"11","author":"Yang","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106877","article-title":"Mechanisms of ceftazidime\/avibactam resistance in drug-na\u00efve bacteraemic enterobacterales strains without metallo-beta-lactamase production: associated with ceftazidime impedance","volume":"62","author":"Xiong","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0036","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106011","article-title":"Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant enterobacterales: ompk36 L3 alterations and \u03b2-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values","volume":"56","author":"Castanheira","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0038","doi-asserted-by":"crossref","first-page":"124.e1","DOI":"10.1016\/j.cmi.2019.08.020","article-title":"Emergence of ceftazidime\/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00924-23","article-title":"Genome sequencing unveils blaKPC-2-harboring plasmids as drivers of enhanced resistance and virulence in nosocomial Klebsiella pneumoniae","volume":"9","author":"Han","year":"2024","journal-title":"mSystems"},{"key":"10.1016\/j.ijantimicag.2026.107774_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010334","article-title":"Widespread emergence of OmpK36 loop 3 insertions among multidrug-resistant clones of Klebsiella pneumoniae","volume":"18","author":"David","year":"2022","journal-title":"PLoS Pathog"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T19:02:57Z","timestamp":1779735777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0924857926000634"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107774","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftazidime\/avibactam-resistant carbapenem-resistant Klebsiella pneumoniae in China: A nationwide multicenter study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107774"}}